España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Alumis
ALMS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$11.35
-0.49
-4.14%
At close: -
$11.35
0
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Alumis (ALMS) Forecast
News
Earnings
Alumis (ALMS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Alumis (NASDAQ:ALMS) Stock
Alumis Stock (NASDAQ: ALMS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, October 31, 2024
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Baird Initiates Coverage On Alumis with Outpe...
Benzinga Newsdesk
Thursday, October 17, 2024
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Vandana Singh
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Alumis shares are trading higher after HC Wai...
Benzinga Newsdesk
HC Wainwright & Co. Initiates Coverage On Alu...
Benzinga Newsdesk
Wednesday, October 09, 2024
Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
Avi Kapoor
Friday, September 27, 2024
Alumis shares are trading lower. The company ...
Benzinga Newsdesk
Alumis Presents 28-Week Data From Open Label ...
Benzinga Newsdesk
Tuesday, August 27, 2024
Samsara Biocapital LP Reports 6.9% Stake In A...
Benzinga Newsdesk
Monday, August 19, 2024
Cantor Fitzgerald Reiterates Overweight on Al...
Benzinga Newsdesk
Tuesday, August 13, 2024
Alumis Reports Q2 Net Loss Of $(56.5)M, Down ...
Benzinga Newsdesk
Wednesday, July 31, 2024
Alumis shares are trading higher. The company...
Benzinga Newsdesk
Monday, July 29, 2024
Alumis Initiates ONWARD Phase 3 Clinical Prog...
Benzinga Newsdesk
Wednesday, July 24, 2024
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Vandana Singh
CORRECTION: Cantor Fitzgerald Initiates Cover...
Benzinga Newsdesk
Tuesday, July 23, 2024
Guggenheim Initiates Coverage On Alumis with ...
Benzinga Newsdesk
Cantor Fitzgerald Initiates Coverage On Alumi...
Benzinga Newsdesk
Leerink Partners Initiates Coverage On Alumis...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Alumis w...
Benzinga Newsdesk
Friday, June 28, 2024
Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering
Vandana Singh
Alumis IPO Price Indicating $12.25/Share On 4...
Benzinga Newsdesk
Alumis IPO Price Indicating $12/Share; IPO Pr...
Benzinga Newsdesk
Trading Halt: Halt status updated at 10:10:00...
Benzinga Newsdesk
Reported Earlier, Alumis Prices Its IPO Of 13...
Benzinga Newsdesk
Thursday, June 27, 2024
Alumis Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch